215 related articles for article (PubMed ID: 28262735)
1. Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma.
Ramachandran R; Junnuthula VR; Gowd GS; Ashokan A; Thomas J; Peethambaran R; Thomas A; Unni AK; Panikar D; Nair SV; Koyakutty M
Sci Rep; 2017 Mar; 7():43271. PubMed ID: 28262735
[TBL] [Abstract][Full Text] [Related]
2. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model.
Brem S; Tyler B; Li K; Pradilla G; Legnani F; Caplan J; Brem H
Cancer Chemother Pharmacol; 2007 Oct; 60(5):643-50. PubMed ID: 17256133
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
Anai S; Hide T; Takezaki T; Kuroda J; Shinojima N; Makino K; Nakamura H; Yano S; Kuratsu J
Cancer Sci; 2014 May; 105(5):583-91. PubMed ID: 24673719
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide and MGMT forever?
Weller M
Neuro Oncol; 2010 Mar; 12(3):219-20. PubMed ID: 20167809
[No Abstract] [Full Text] [Related]
5. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells.
Zhang R; Saito R; Shibahara I; Sugiyama S; Kanamori M; Sonoda Y; Tominaga T
J Neurooncol; 2016 Jan; 126(2):235-42. PubMed ID: 26530267
[TBL] [Abstract][Full Text] [Related]
7. Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection.
Akbar U; Jones T; Winestone J; Michael M; Shukla A; Sun Y; Duntsch C
J Neurooncol; 2009 Sep; 94(2):203-12. PubMed ID: 19337695
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats.
Zhang YH; Zhang H; Liu JM; Yue ZJ
Med Oncol; 2011 Sep; 28(3):901-6. PubMed ID: 20396980
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide in the treatment of recurrent malignant glioma.
Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
[TBL] [Abstract][Full Text] [Related]
10. The use of TMZ embedded hydrogels for the treatment of orthotopic human glioma xenografts.
Adhikari B; Li J; Brandel MG; Futalan D; Akers J; Deming T; Chen CC; Carter BS
J Clin Neurosci; 2017 Nov; 45():288-292. PubMed ID: 28867360
[TBL] [Abstract][Full Text] [Related]
11. Electrospun PVA-Dacarbazine nanofibers as a novel nano brain-implant for treatment of glioblastoma: in silico and in vitro characterization.
Steffens L; Morás AM; Arantes PR; Masterson K; Cao Z; Nugent M; Moura DJ
Eur J Pharm Sci; 2020 Feb; 143():105183. PubMed ID: 31846696
[TBL] [Abstract][Full Text] [Related]
12. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
Cancer Biol Ther; ; . PubMed ID: 19738431
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
